RxDoctor Payments Data

Jimmy Tarpley, DO

Family Medicine · Denison, TXNPI 1255377487

Payments from drug & device makers

$1,286in general payments, 2019–2025

Across 29 payments — averaging $44.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$996
  • Johnson & Johnson$82
  • GSK$81
  • Abbott$37
  • AbbVie$25
  • Avanir Pharmaceuticals, Inc.$16
  • plus $50 from 4 others

What the payments were for

  • Consulting fees$87068%
  • Food & beverage$41632%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,286 in reported general payments places this provider in the 65th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$229,679
Medicare patients
417
Services billed
5,185

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide83$115,145
OzempicSemaglutide52$66,919
EliquisApixaban73$59,392
JardianceEmpagliflozin46$58,150
MounjaroTirzepatide42$56,918
XareltoRivaroxaban35$28,848
JanuviaSitagliptin Phosphate36$28,129
FarxigaDapagliflozin Propanediol34$25,811
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog28$22,264
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$18,913
TrulicityDulaglutide15$17,661
Soliqua 100-33Insulin Glargine/Lixisenatide16$17,495
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$15,168
LinzessLinaclotide23$11,775
NamzaricMemantine Hcl/Donepezil Hcl12$10,550

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$996$182,064135 claims
PfizerEliquis, Premarin, Paxlovid$12$69,853117 claims
Boehringer IngelheimJardiance$14$58,15046 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$81$44,50167 claims
Johnson & JohnsonXarelto$82$28,84835 claims
MerckJanuvia$12$28,12936 claims
AbbVieLinzess, Namzaric, Synthroid$25$25,725110 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Denison

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →